This post was originally published on this site
Gomez’s appointment was announced in April and came into effect on Monday. Moderna (NASDAQ:MRNA) said he left on Tuesday after Dentsply Sirona said it will not file its quarterly report with U.S. securities regulators on time due to the investigation.
The investigation by the dental products maker was focused on the use of incentives to sell products to distributors and whether those incentives were properly accounted for.
Moderna said recently retired CFO David Meline will return to the role of finance chief.
Gomez will receive 12 months’ salary, totaling $700,000, and forfeit his signing bonus and bonus eligibility, the vaccine maker said.
